+Vote!
www.OSIR.org.in (Free subscription) | 21/11/2008
Medical device maker NuVasive Inc. maintained its 2008 profit forecast, but predicted increased revenue that was above Wall Street expectations. NuVasive (nasdaq: NUVA - news - people ) now expects revenue of $245 million to $247 million, up from its Source: www.forbes.com Amylin, Orient-Express, PFG, Sun: U.S. Equity Movers (Correct) - BloombergNov. 4 (Bloomberg) [...]
+Vote!
www.OSIR.org.in (Free subscription) | 21/11/2008
Looking for stocks that should benefit now that Senator Obama is officially President-Elect Obama? Many investors believe that liberals negatively impact stock markets in general and that the only companies to benefit from a liberal adminstration are Source: www.bloggingstocks.com NuVasive raises revenue outlook for 2008 - ForbesMedical device maker NuVasive Inc. maintained its 2008 [...]
+Vote!
www.OSIR.org.in (Free subscription) | 19/11/2008
Nov. 4 (Bloomberg) — The following companies are having unusual price changes in U.S. trading today. Stock symbols are in parentheses, and share prices are as of 12:15 p.m. in New York. Amylin Pharmaceuticals Inc. (AMLN US) retreated 21 percent to Source: www.bloomberg.com Genzyme, Osiris ink $1B deal - Boston Business JournalGenzyme Corp. has [...]
+Vote!
www.OSIR.org.in (Free subscription) | 18/11/2008
Nov. 4 (Bloomberg) — The following companies are having unusual price changes in U.S. trading today. Stock symbols are in parentheses, and share prices are as of 12:15 p.m. in New York. Amylin Pharmaceuticals Inc. (AMLN US) retreated 21 percent to Source: www.bloomberg.com UPDATE 1-Genzyme, Osiris to develop stem cell products - ReutersNov 4 [...]
+Vote!
www.OSIR.org.in (Free subscription) | 18/11/2008
... today. Stock symbols are in parentheses, and share prices are as of 12:15 p.m. in New York. Amylin Pharmaceuticals Inc. (AMLN US) retreated 21 percent to Source: www.bloomberg.com